Pentoxifylline for intermittent claudication
https://doi.org/10.21518/2079-701X-2015-4-52-57
Abstract
Obliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication. The pain occurs only as long as a specific physical activity is undertaken. Intermittent claudication is registered in 6,4-15,5 per 1 000 people over 55 years old. The article describes the basic principles of treatment and evaluates the efficacy of pentoxifylline.
References
1. HIATT WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med, 2001, 344: 1608-1621.
2. Gillings DB. Pentoxifylline and intermittent claudication: review of clinical trials and cost effectiveness analyses. J Cardiovasc Pharmacol., 1995, 25(2): 44-50.
3. Leng GC, Lee AJ, Fowkes FG, Whiteman M, Dunbar J, Housley E et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. International Journal of Epidemiology, 1996, 25(6): 1172-81.
4. Meijer WT, Cost B, Bernsen RM, Hoes AW, Incidence and management of intermittent claudication in primary care in The Netherlands. Scandinavian Journal of Primary Health Care, 2002, 20(1): 33-4.
5. Dormandy J, Heeck L, Vig S. The natural history of claudication: risk to life and limb. Seminars in Vascular Surgery, 1999, 12(2): 123-37.
6. Coffman JD. Vasodilator drugs in peripheral vascular disease. N Engl J Med, 1979, 300: 713-7,
7. Trental (pentoxifylline) product information. Kansas City, MO: Hoechst Marion Roussel.
8. Dawson DL, Cutler BS, Meissner MH et al. Cilostazol has beneficial effects in treatment of intermittent claudication. Circulation, 1998, 98: 678-86.
9. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs, 1987, 34: 50-97.
10. Samlaska CP, Winfield EA. Pentoxifylline. J Am Acad Dermatol, 1994, 30: 603-21.
11. Yoshitomi Y, Kojima S, Sugi T et al. Antiplatelet treatment with cilostazol after stent implantation. Heart, 1999, 80: 393-6.
12. Girolami A, Buller HR. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a metaanalysis. Arch Intern Med, 1999, 159: 337-45.
13. Hood SC, Moher D, Barber GG. Management of intermittent claudication with pentoxifylline: a meta-analysis of randomized controlled trials. Can Med Assoc J, 1996, 155: 1053-9.
14. Ernst E. Pentoxifylline for intermittent claudication: a critical review. Angiology, 1994, 45: 339-45.
15. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med, 1990, 113: 135-46.
16. Ernst E, Kollar L, Resch KL. Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial. Angiology, 1992, 43: 121-5.
17. Porter JM, Cutler BS, Lee BY et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J, 1982, 104: 66-72.
18. Lindgarde F, Jelnes R, Bjorkman H et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group. Circulation, 1989, 80: 1549-56.
19. Roekaerts F, Deleers L. Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration. Angiology, 1984, 35: 396-406.
20. Di Perri T, Guerrini M. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent clau-dication. Angiology, 1983, 34: 40-5.
21. Green RM, McNamara J. The effects of pentoxi-fylline on patients with intermittent claudication. J Vase Surg, 1988, 7: 356-62.
22. Покровский А.В., Калинин А.А., Чупин А.В., Замский К.С., Колосов Р.В., Маркосян АА. Вазонит ретард в лечении больных с перемежающейся хромотой при облитерирующих заболеваниях артерий нижних конечностей. Ангиология и сосудистая хирургия, 2003, 9(2): 19.
23. Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA. Pentoxifylline for intermittent claudication. Cochrane Database of Systematic Reviews, 2012, Issue 1. Art. No.: CD005262. DOI: 10.1002/14651858.CD005262. pub2.
24. Национальные рекомендации по ведению пациентов с патологией артерий нижних конечностей: ангиология и сосудистая хирургия. Приложение. 2013. 19(2): 1-67.
Review
For citations:
Vaulin NA. Pentoxifylline for intermittent claudication. Meditsinskiy sovet = Medical Council. 2015;(4):52-57. (In Russ.) https://doi.org/10.21518/2079-701X-2015-4-52-57
Views:
669
Email this article 